drugset / Trial / NCT00944502

To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins

NCT00944502 ↗

Phase 3 Unknown 104 enrolled Bunker Industria Farmaceutica Ltda.
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the efficacy and tolerability of Vitatonus Dexa compared with dexamethasone in the signs and symptoms of neuralgia of various origins. Clinical study, randomized prospective and random in nature, with a patients diagnosed with neuralgia of diverse origin. Patients will be include in sufficient quantity to achieve the minimum of 104 evaluable patients.

Timeline

Start
2009-10
Primary completion
2009-11
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Intramuscular

Indications